F573 Ia Clinical Trial

NCT04820049 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Tolerance
Pharmacokinetic

Interventions

DRUG: F573
OTHER: Placebo

Sponsor

Beijing Continent Pharmaceutical Co, Ltd.